|
1
|
Wongdee K and Charoenphandhu N:
Osteoporosis in diabetes mellitus: possible cellular and molecular
mechanisms. World J Diabetes. 2:41–48. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cervellati C, Bonaccorsi G, Cremonini E,
Bergamini CM, Patella A, Castaldini C, Ferrazzini S, Capatti A,
Picarelli V, Pansini FS and Massari L: Bone mass density
selectively correlates with serum markers of oxidative damage in
post-menopausal women. Clin Chem Lab Med. 51:333–338. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fatokun AA, Stone TW and Smith RA:
Responses of differentiated MC3T3-E1 osteoblast-like cells to
reactive oxygen species. Eur J Pharmacol. 587:35–41. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sheweita SA and Khoshhal KI: Calcium
metabolism and oxidative stress in bone fractures: role of
antioxidants. Curr Drug Metab. 8:519–525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Witko-Sarsat V, Friedlander M,
Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers
P and Descamps-Latscha B: Advanced oxidation protein products as a
novel marker of oxidative stress in uremia. Kidney Int.
49:1304–1313. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Witko-Sarsat V, Friedlander M, Nguyen Khoa
T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers
P, Drueke T and Descamps-Latscha B: Advanced oxidation protein
products as novel mediators of inflammation and monocyte activation
in chronic renal failure. J Immunol. 161:2524–2532. 1998.PubMed/NCBI
|
|
7
|
Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N,
Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D and
Zhang X: Advanced oxidation protein products activate vascular
endothelial cells via a RAGE-mediated signaling pathway. Antioxid
Redox Signal. 10:1699–1712. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piwowar A: Advanced oxidation protein
products. Part I. Mechanism of the formation, characteristics and
property. Pol Merkur Lekarski. 28:166–169. 2010.(In Polish).
|
|
9
|
Piwowar A, Knapik-Kordecka M and Warwas M:
AOPP and its relations with selected markers of
oxidative/antioxidative system in type 2 diabetes mellitus.
Diabetes Res Clin Pract. 77:188–192. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cumaoglu A, Cevik C, Rackova L, Ari N and
Karasu C: Effects of antioxidant stobadine on protein
carbonylation, advanced oxidation protein products and reductive
capacity of liver in streptozotocin-diabetic rats: role of
oxidative/nitrosative stress. BioFactors. 30:171–178. 2007.
View Article : Google Scholar
|
|
11
|
Krzystek-Korpacka M, Neubauer K, Berdowska
I, Boehm D, Zielinski B, Petryszyn P, Terlecki G, Paradowski L and
Gamian A: Enhanced formation of advanced oxidation protein products
in IBD. Inflamm Bowel Dis. 14:794–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kaneda H, Taguchi J, Ogasawara K, Aizawa T
and Ohno M: Increased level of advanced oxidation protein products
in patients with coronary artery disease. Atherosclerosis.
162:221–225. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collet C, Schiltz C, Geoffroy V, Maroteaux
L, Launay JM and de Vernejoul MC: The serotonin 5-HT2B receptor
controls bone mass via osteoblast recruitment and proliferation.
FASEB J. 22:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang YB, Zhong ZM, Hou G, Jiang H and
Chen JT: Involvement of oxidative stress in age-related bone loss.
J Surg Res. 169:e37–e42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi EM and Kim YH: Hesperetin attenuates
the highly reducing sugar-triggered inhibition of osteoblast
differentiation. Cell Biol Toxicol. 24:225–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee KH and Choi EM: Myricetin, a naturally
occurring flavonoid, prevents 2-deoxy-D-ribose induced dysfunction
and oxidative damage in osteoblastic MC3T3-E1 cells. Eur J
Pharmacol. 591:1–6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong ZM, Bai L and Chen JT: Advanced
oxidation protein products inhibit proliferation and
differentiation of rat osteoblast-like cells via NF-kappaB pathway.
Cell Physiol Biochem. 24:105–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rodan GA and Martin TJ: Therapeutic
approaches to bone diseases. Science. 289:1508–1514. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Long MW: Osteogenesis and
bone-marrow-derived cells. Blood Cells Mol Dis. 27:677–690. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dalle Carbonare L, Valenti MT, Zanatta M,
Donatelli L and Lo Cascio V: Circulating mesenchymal stem cells
with abnormal osteogenic differentiation in patients with
osteoporosis. Arthritis Rheum. 60:3356–3365. 2009.PubMed/NCBI
|
|
22
|
Benisch P, Schilling T, Klein-Hitpass L,
Frey SP, Seefried L, Raaijmakers N, Krug M, Regensburger M, Zeck S,
Schinke T, Amling M, Ebert R and Jakob F: The transcriptional
profile of mesenchymal stem cell populations in primary
osteoporosis is distinct and shows overexpression of osteogenic
inhibitors. PloS One. 7:e451422012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kume S, Kato S, Yamagishi S, Inagaki Y,
Ueda S, Arima N, Okawa T, Kojiro M and Nagata K: Advanced glycation
end-products attenuate human mesenchymal stem cells and prevent
cognate differentiation into adipose tissue, cartilage, and bone. J
Bone Miner Res. 20:1647–1658. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Farley JR and Jorch UM: Differential
effects of phospholipids on skeletal alkaline phosphatase activity
in extracts, in situ and in circulation. Arch Biochem Biophys.
221:477–488. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harada S and Rodan GA: Control of
osteoblast function and regulation of bone mass. Nature.
423:349–355. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng YQ, Fu Y, Su XP and Tang ZY: Biologic
effects of advanced oxidative protein products on the human
gingival fibroblasts. Zhonghua Kou Qiang Yi Xue Za Zhi. 44:270–273.
2009.(In Chinese).
|
|
27
|
Ouyang P, Liu S, Bei W, Lai W, Hou F and
Xu A: Effects of flavone from leaves of Diospyros kaki on
adventitial fibroblasts proliferation by advanced oxidation protein
products in vitro. Zhong Yao Cai. 27:186–188. 2004.(In
Chinese).
|
|
28
|
Siggelkow H, Rebenstorff K, Kurre W,
Niedhart C, Engel I, Schulz H, Atkinson MJ and Hufner M:
Development of the osteoblast phenotype in primary human
osteoblasts in culture: comparison with rat calvarial cells in
osteoblast differentiation. J Cell Biochem. 75:22–35. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beck GR Jr, Sullivan EC, Moran E and
Zerler B: Relationship between alkaline phosphatase levels,
osteopontin expression, and mineralization in differentiating
MC3T3-E1 osteoblasts. J Cell Biochem. 68:269–280. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM
and Luo SQ: Oxidative stress inhibits osteoblastic differentiation
of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun.
314:197–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee NK, Choi YG, Baik JY, Han SY, Jeong
DW, Bae YS, Kim N and Lee SY: A crucial role for reactive oxygen
species in RANKL-induced osteoclast differentiation. Blood.
106:852–859. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Barbagallo I, Vanella A, Peterson SJ, Kim
DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo GA, Di
Raimondo F, Abraham NG and Asprinio D: Overexpression of heme
oxygenase-1 increases human osteoblast stem cell differentiation. J
Bone Mineral Metab. 28:276–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan SF, Ramasamy R and Schmidt AM: The
RAGE axis: a fundamental mechanism signaling danger to the
vulnerable vasculature. Circ Res. 106:842–853. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wautier MP, Chappey O, Corda S, Stern DM,
Schmidt AM and Wautier JL: Activation of NADPH oxidase by AGE links
oxidant stress to altered gene expression via RAGE. Am J Physiol
Endocrinol Metab. 280:E685–E694. 2001.PubMed/NCBI
|
|
35
|
Yamagishi S: Role of advanced glycation
end products (AGEs) in osteoporosis in diabetes. Curr Drug Targets.
12:2096–2102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li G, Xu J and Li Z: Receptor for advanced
glycation end products inhibits proliferation in osteoblast through
suppression of Wnt, PI3K and ERK signaling. Biochem Biophys Res
Commun. 423:684–689. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding KH, Wang ZZ, Hamrick MW, Deng ZB,
Zhou L, Kang B, Yan SL, She JX, Stern DM, Isales CM and Mi QS:
Disordered osteoclast formation in RAGE-deficient mouse establishes
an essential role for RAGE in diabetes related bone loss. Biochem
Biophys Res Commun. 340:1091–1097. 2006. View Article : Google Scholar : PubMed/NCBI
|
